Evidence map›Paper›PMID 34964688›Full record

ReviewPhysiology (Bethesda, Md.)2022

Uterine Fibroids: Hiding in Plain Sight.

Elizabeth A Stewart, Romana A Nowak

Abstract readReview
In one paragraph

Review in Physiology (Bethesda, Md.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Uterine fibroids in women diagnosed with acromegaly: a systematic review.Reviews in endocrine & metabolic disorders · 2024
    Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Update on Endovascular Therapy for Fibroids and Adenomyosis.Seminars in interventional radiology · 2023
    Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Elizabeth A StewartDivision of Reproductive Endocrinology and Infertility, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0003-1110-2400
Romana A NowakDepartment of Animal Sciences, University of Illinois, Urbana, Illinois.

Funding

COMPARE-UFP50HS023418 · AHRQ · DUKE UNIVERSITY · PI MYERS, EVAN R. · 2014 to 2019
$20.0M
Uterine Leiomyoma Research Center ProgramP01HD057877 · NICHD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MARSH, ERICA E · 2009 to 2019
$12.2M
Dietary Supplementation with Flax as a Therapeutic Approach for LeiomyomasR21HD085530 · NICHD · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI NOWAK, ROMANA A. · 2016 to 2017
$436k
AHRQ HHS P50 HS023418NICHD NIH HHS P01 HD057877NICHD NIH HHS R21 HD085530
6 · The paper itself

Abstract

Uterine fibroids (leiomyomas) are present in >75% of women and can cause serious morbidity. They are by far the leading cause of hysterectomy. Fibroids are a complex mixture of cells that include fibroblasts and smooth muscle cells. Rich in extracellular matrix, they typically arise through somatic mutations, most commonly

Indexed as

LeiomyomaUterine NeoplasmsFemaleHumansHysterectomyfibroidhysterectomyleiomyomapathogenesistreatment

Identifiers

PMID34964688
PMCPMC8742728

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.